US Federal 2023-2024 Regular Session

US Federal Senate Bill SB727

Introduced
3/9/23  

Caption

Insulin for All Act of 2023

Impact

If enacted, SB727 would significantly impact the current landscape of insulin pricing and distribution. The bill is expected to decrease out-of-pocket expenses for millions of Americans who depend on insulin, thereby alleviating a financial crisis faced by many diabetic patients. Furthermore, it could push manufacturers to reconsider their pricing strategies and improve their production efficiency in order to comply with the new regulations. Additionally, the act may prompt discussions concerning the pricing of other essential medications, as it sets a precedent for affordable drug policies.

Summary

SB727, known as the Insulin for All Act of 2023, aims to limit the price of insulin in the United States. The proposed legislation mandates that the selling price for insulin by manufacturers cannot exceed $20 per 1000 units. This price cap is intended to improve access for individuals relying on insulin for diabetes management and to address the financial burden posed by rising insulin costs. By establishing a maximum price, the bill seeks to ensure that insulin remains affordable for all, regardless of their financial situation.

Contention

Supporters of the bill argue that it is a necessary step toward ensuring the ethical pricing of lifesaving medication, while detractors may raise concerns about its potential ramifications on pharmaceutical product availability or the incentive for manufacturers to invest in research and development. Critics worry that such a price restriction might lead to reduced competition and innovation within the insulin market, and they call for alternative solutions that do not impose price controls. The effectiveness of this bill could hinge on its implementation logistics and the reactions it elicits from the pharmaceutical industry.

Companion Bills

US HB1485

Same As Insulin for All Act of 2023

Previously Filed As

US SB4189

INSULIN Act of 2026 Improving Needed Safeguards for Users of Lifesaving Insulin Now Act of 2026

US HB35

Close the Medigap Act of 2023 This bill (1) expands guaranteed issue rights with respect to Medigap policies (Medicare supplemental health insurance policies), (2) eliminates certain limitations on Medigap policies for newly eligible Medicare beneficiaries, and (3) modifies other provisions related to Medigap policies. (Guaranteed issue rights require that a policy be offered to any eligible applicant without regard to health status.)

US HB252

Inflation Prevention Act of 2023 This bill establishes a point of order that, when the annualized rate of inflation exceeds 4.5%, prohibits the House and Senate from considering legislation that provides new budget authority and is estimated to increase the Consumer Price Index for All Urban Consumers. The prohibition may be waived in the Senate by an affirmative vote of three-fifths of the Senate.

US HB33

Medicare Dental, Vision, and Hearing Benefit Act of 2023 This bill provides for Medicare coverage of dental, vision, and hearing care. Coverage includes (1) routine dental cleanings and exams, basic and major dental services, emergency dental care, and dentures; (2) routine eye exams, eyeglasses, and contact lenses; and (3) routine hearing exams, hearing aids, and exams for hearing aids. With respect to such care, the bill establishes special payment rules, limitations, and coinsurance requirements.

US HB170

Domestic Security Using Production Partnerships and Lessons from Yesterday Act of 2023 or the Domestic SUPPLY Act of 2023 This bill establishes a program and sets out other requirements to promote domestic manufacturing of personal protective equipment (PPE) for infectious diseases and other public health emergencies. The Department of Health and Human Services (HHS) must establish a program to enter into purchasing agreements for PPE produced domestically by manufacturers that are majority-owned and -operated by U.S. citizens. HHS must coordinate with the Department of Defense and the Department of Homeland Security on this program. In addition, the federal government must only procure, subject to limited exceptions, PPE that is produced domestically to prevent the transmission of an infectious disease. If using federal funds, states or localities must also procure PPE domestically. Further, the bill requires HHS to consult with the Occupational Safety and Health Administration on a report about changes to federal requirements for PPE during the COVID-19 pandemic and the impact of those changes on health care workers who cared for patients in 2020 and 2021.

US HB8

Drug Pricing Transparency and Accountability Act

US SB4512

Affordable Insulin Now Act of 2026

US HB2636

Making Insulin Affordable for All Children Act

US HB38

Concealed Carry Reciprocity Act This bill establishes a federal statutory framework to regulate the carry or possession of concealed firearms across state lines. Specifically, an individual who is eligible to carry a concealed firearm in one state may carry or possess a concealed handgun (other than a machine gun or destructive device) in another state that allows its residents to carry concealed firearms. It sets forth requirements for the lawful concealed carry across state lines. The bill preempts most state and local laws related to concealed carry and establishes a private right of action for a person adversely affected by interference with a concealed-carry right established by this bill.

US HB65

Ending Common Core and Expanding School Choice Act This bill revises requirements related to federal education funding for disadvantaged children. Specifically, the bill (1) eliminates the standards, assessments, and academic accountability requirements for state and local educational agencies that receive federal funds for the education of disadvantaged children; (2) requires such funds to be allocated based on the number of children residing in each state who are living in poverty; and (3) allows educational agencies to distribute per-pupil amounts from such funds to parents for qualified elementary and secondary education expenses. The bill prohibits federal officers or employees from mandating academic standards, assessments, curricula, or accountability systems.

Similar Bills

No similar bills found.